Keyphrases
Older Patients
100%
Glioblastoma multiforme
100%
Carmustine Wafer
100%
Median Survival
30%
Wafer
30%
Operative
20%
No Significant Difference
10%
Consecutive Patients
10%
Karnofsky Performance Status
10%
Temozolomide
10%
Radiation Therapy
10%
Survival Curve
10%
Long-term Survival
10%
Peri
10%
Kaplan-Meier Plot
10%
Subgroup Analysis
10%
Prolonged Survival
10%
Mean Standard Deviation
10%
Peak Incidence
10%
Extent of Resection
10%
Rank Analysis
10%
Nursing and Health Professions
Glioblastoma
100%
Carmustine
100%
Perioperative
10%
Surgery
10%
Vascular Guide Wire
10%
Radiotherapy
10%
Survival Rate
10%
Karnofsky Performance Status
10%
Temozolomide
10%
Medicine and Dentistry
Glioblastoma
100%
Carmustine
100%
Radiation Therapy
10%
Surgery
10%
Karnofsky Performance Status
10%
Survival Rate
10%
Temozolomide
10%
Subgroup Analysis
10%
Pharmacology, Toxicology and Pharmaceutical Science
Glioblastoma
100%
Carmustine
100%
Survival Rate
10%
Temozolomide
10%
Neuroscience
Glioblastoma Multiforme
100%
Carmustine
100%
Radiation Therapy
10%
Temozolomide
10%